AKTX

AKTX

USD

Akari Therapeutics plc ADS

$0.750-0.030 (-3.834%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$0.780

高値

$0.790

安値

$0.721

出来高

0.21M

企業ファンダメンタルズ

時価総額

24.5M

業種

バイオテクノロジー

United States

取引統計

平均出来高

0.21M

取引所

NCM

通貨

USD

52週レンジ

安値 $0.571現在値 $0.750高値 $2.563

関連ニュース

GlobeNewswire

Akari Therapeutics' Accepted Abstract Showcasing its Novel Splicing-Targeted ADC Payload Driving Immune Activation Now Available

BOSTON and LONDON, Nov. 04, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing novel payloads for antibody drug conjugates (ADCs), today announced its abstract

もっと見る
Akari Therapeutics' Accepted Abstract Showcasing its Novel Splicing-Targeted ADC Payload Driving Immune Activation Now Available
GlobeNewswire

Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP

BOSTON and LONDON, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced the formation of

もっと見る
Akari Therapeutics Announces Formation of Scientific Advisory Board and Inaugural Appointment of Renowned Medical Oncologist, Sara A. Hurvitz, MD, FACP
GlobeNewswire

Akari Therapeutics Announces Launch of CEO Corner Platform

CEO Corner segments to provide added perspective to press releases, corporate developments and pipeline progress Provides interested parties with the ability to ask questions and submit topics for future videos Access

もっと見る
Akari Therapeutics Announces Launch of CEO Corner Platform
GlobeNewswire

Akari Therapeutics Announces $2.5 Million Registered Direct Offering

BOSTON and LONDON, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ:AKTX) (the "Company"), an oncology biotechnology company developing novel payload antibody drug conjugates (ADCs), today announced

もっと見る
Akari Therapeutics Announces $2.5 Million Registered Direct Offering